Published in Leukemia on July 20, 2006
FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors. J Exp Med (2007) 4.59
The c-MYC oncoprotein, the NAMPT enzyme, the SIRT1-inhibitor DBC1, and the SIRT1 deacetylase form a positive feedback loop. Proc Natl Acad Sci U S A (2011) 1.90
Phosphorylation regulates c-Myc's oncogenic activity in the mammary gland. Cancer Res (2011) 1.54
Myc protein is stabilized by suppression of a novel E3 ligase complex in cancer cells. Genes Dev (2010) 1.46
PTEN loss defines a PI3K/AKT pathway-dependent germinal center subtype of diffuse large B-cell lymphoma. Proc Natl Acad Sci U S A (2013) 1.44
MYC degradation. Cold Spring Harb Perspect Med (2014) 1.42
Increased μ-Calpain Activity in Blasts of Common B-Precursor Childhood Acute Lymphoblastic Leukemia Correlates with Their Lower Susceptibility to Apoptosis. PLoS One (2015) 1.39
The Axin1 scaffold protein promotes formation of a degradation complex for c-Myc. EMBO J (2009) 1.33
Decorin antagonizes Met receptor activity and down-regulates {beta}-catenin and Myc levels. J Biol Chem (2010) 1.32
Targeting c-MYC by antagonizing PP2A inhibitors in breast cancer. Proc Natl Acad Sci U S A (2014) 1.25
Myc roles in hematopoiesis and leukemia. Genes Cancer (2010) 1.23
Glycogen synthase kinase-3 and cancer: good cop, bad cop? Cancer Cell (2008) 1.17
Mechanistic insight into Myc stabilization in breast cancer involving aberrant Axin1 expression. Proc Natl Acad Sci U S A (2011) 1.16
A tumor suppressor role for PP2A-B56alpha through negative regulation of c-Myc and other key oncoproteins. Cancer Metastasis Rev (2008) 1.14
Pin1 regulates the dynamics of c-Myc DNA binding to facilitate target gene regulation and oncogenesis. Mol Cell Biol (2013) 1.01
Enhancers of Polycomb EPC1 and EPC2 sustain the oncogenic potential of MLL leukemia stem cells. Leukemia (2013) 0.87
Regulation of c-Myc Protein Abundance by a Protein Phosphatase 2A-Glycogen Synthase Kinase 3β-Negative Feedback Pathway. Genes Cancer (2012) 0.85
Clinical significance of high c-MYC and low MYCBP2 expression and their association with Ikaros dysfunction in adult acute lymphoblastic leukemia. Oncotarget (2015) 0.84
Protein kinase A regulates MYC protein through transcriptional and post-translational mechanisms in a catalytic subunit isoform-specific manner. J Biol Chem (2013) 0.83
Characterization of ARF-BP1/HUWE1 interactions with CTCF, MYC, ARF and p53 in MYC-driven B cell neoplasms. Int J Mol Sci (2012) 0.81
CRY2 and FBXL3 Cooperatively Degrade c-MYC. Mol Cell (2016) 0.79
Prediction of oncogenic interactions and cancer-related signaling networks based on network topology. PLoS One (2013) 0.79
10058-F4, a c-Myc inhibitor, markedly increases valproic acid-induced cell death in Jurkat and CCRF-CEM T-lymphoblastic leukemia cells. Oncol Lett (2014) 0.79
Gamabufotalin triggers c-Myc degradation via induction of WWP2 in multiple myeloma cells. Oncotarget (2016) 0.77
The role of deubiquitinases in breast cancer. Cancer Metastasis Rev (2016) 0.75
Studying c-Myc serine 62 phosphorylation in leukemia cells: concern over antibody cross-reactivity. Blood (2012) 0.75
Stabilization of the c-Myc Protein by CAMKIIγ Promotes T Cell Lymphoma. Cancer Cell (2017) 0.75
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature (1996) 26.30
Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature (1983) 19.76
Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell (1983) 17.87
Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci U S A (1982) 11.15
Reversible tumorigenesis by MYC in hematopoietic lineages. Mol Cell (1999) 8.03
MYC oncogenes and human neoplastic disease. Oncogene (1999) 7.28
Onc gene amplification in promyelocytic leukaemia cell line HL-60 and primary leukaemic cells of the same patient. Nature (1982) 6.78
c-MYC: more than just a matter of life and death. Nat Rev Cancer (2002) 6.73
A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nat Cell Biol (2004) 6.61
Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. Genes Dev (2000) 6.54
Proteins encoded by the human c-myc oncogene: differential expression in neoplastic cells. Mol Cell Biol (1984) 5.79
The myc oncogene: its role in transformation and differentiation. Annu Rev Genet (1986) 5.40
The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation. Proc Natl Acad Sci U S A (2004) 5.37
Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants. Nature (2005) 4.97
Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7. EMBO J (2004) 4.95
Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis. EMBO J (2005) 4.82
Rapid cytoplasmic turnover of c-myc mRNA: requirement of the 3' untranslated sequences. Mol Cell Biol (1987) 3.99
A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice. Genes Dev (1993) 3.60
New light on Myc and Myb. Part I. Myc. Genes Dev (1990) 3.57
Destruction of Myc by ubiquitin-mediated proteolysis: cancer-associated and transforming mutations stabilize Myc. EMBO J (1999) 3.50
Differential regulation of glycogen synthase kinase 3beta by insulin and Wnt signaling. J Biol Chem (2000) 3.28
Myc-induced T cell leukemia in transgenic zebrafish. Science (2003) 3.15
c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells. Mol Cell Biol (2000) 2.96
Ras enhances Myc protein stability. Mol Cell (1999) 2.91
Phosphorylation by glycogen synthase kinase-3 controls c-myc proteolysis and subnuclear localization. J Biol Chem (2003) 2.66
The life cycle of C-myc: from synthesis to degradation. Cell Cycle (2004) 2.56
Deregulated expression of c-myc by murine erythroleukaemia cells prevents differentiation. Nature (1986) 2.54
Point mutations in the c-Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas. Nat Genet (1993) 2.47
The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-kappaB and c-Myc in pancreatic cancer cells. Oncogene (2004) 2.35
c-Myc hot spot mutations in lymphomas result in inefficient ubiquitination and decreased proteasome-mediated turnover. Blood (2000) 2.08
PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanismsin haematological malignancies. Hum Mol Genet (1999) 2.08
Hierarchical phosphorylation at N-terminal transformation-sensitive sites in c-Myc protein is regulated by mitogens and in mitosis. Mol Cell Biol (1994) 2.01
myc boxes, which are conserved in myc family proteins, are signals for protein degradation via the proteasome. Mol Cell Biol (1998) 1.77
c-myc protein expression in untransformed fibroblasts. Oncogene (1991) 1.72
Mutations in the coding region of c-MYC in AIDS-associated and other aggressive lymphomas. Cancer Res (1994) 1.37
Mutations in the coding region of c-myc occur frequently in acquired immunodeficiency syndrome-associated lymphomas. Blood (1994) 1.28
Enhanced translation and increased turnover of c-myc proteins occur during differentiation of murine erythroleukemia cells. Mol Cell Biol (1990) 1.27
Differing roles of Akt and serum- and glucocorticoid-regulated kinase in glucose metabolism, DNA synthesis, and oncogenic activity. J Biol Chem (2003) 1.25
Aberrant somatic hypermutation in multiple subtypes of AIDS-associated non-Hodgkin lymphoma. Blood (2003) 1.19
Functional analysis of Burkitt's lymphoma mutant c-Myc proteins. J Biol Chem (1996) 1.08
Brusatol-mediated induction of leukemic cell differentiation and G(1) arrest is associated with down-regulation of c-myc. Leukemia (2002) 0.99
Transgenic mouse models for hematopoietic tumorigenesis. Curr Top Microbiol Immunol (1988) 0.92
Oncogene expression in human leukemia. Blood (1984) 0.88
Blocking c-Myc and Max expression inhibits proliferation and induces differentiation of normal and leukemic myeloid cells. Oncogene (1995) 0.88
Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. Mol Endocrinol (2001) 4.34
Independent regulatory elements in the nestin gene direct transgene expression to neural stem cells or muscle precursors. Neuron (1994) 4.00
Changes in the platelet membrane glycoprotein IIb.IIIa complex during platelet activation. J Biol Chem (1985) 3.95
Mucosal T lymphocyte numbers are selectively reduced in integrin alpha E (CD103)-deficient mice. J Immunol (1999) 3.21
Neurogenin promotes neurogenesis and inhibits glial differentiation by independent mechanisms. Cell (2001) 2.93
The role of beta7 integrins in CD8 T cell trafficking during an antiviral immune response. J Exp Med (1999) 2.62
Current insights into the regulation of programmed cell death by NF-kappaB. Oncogene (2006) 2.60
Functional abnormalities in isolated left bundle branch block. The effect of interventricular asynchrony. Circulation (1989) 2.56
Retrofitting houses with insulation to reduce health inequalities: aims and methods of a clustered, randomised community-based trial. Soc Sci Med (2005) 2.54
Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood (1987) 2.43
Structural similarity between the p17 matrix protein of HIV-1 and interferon-gamma. Nature (1994) 2.35
Positional cloning of a novel Fanconi anemia gene, FANCD2. Mol Cell (2001) 2.33
Fecal calprotectin: validation as a noninvasive measure of bowel inflammation in childhood inflammatory bowel disease. J Pediatr Gastroenterol Nutr (2001) 2.33
Fetal valproate syndrome and autism: additional evidence of an association. Dev Med Child Neurol (2001) 2.32
Generation of mucosal cytotoxic T cells against soluble protein by tissue-specific environmental and costimulatory signals. Proc Natl Acad Sci U S A (1998) 2.29
The cell-surface proteoglycan Dally regulates Wingless signalling in Drosophila. Nature (1999) 2.22
A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. J Clin Invest (1998) 2.16
Type-specific inhibition of preopsonization versus immunoprecipitation by Streptococcal M proteins. Infect Immun (1973) 2.13
Chromosomal localization of human leukocyte, fibroblast, and immune interferon genes by means of in situ hybridization. Proc Natl Acad Sci U S A (1982) 2.08
Chlorhexidine droplet splash from a skin preparation gallipot: effect of height of pouring. Anaesthesia (2013) 2.00
Germ cell defects and hematopoietic hypersensitivity to gamma-interferon in mice with a targeted disruption of the Fanconi anemia C gene. Blood (1996) 1.99
Huntington disease-linked restriction fragment length polymorphism localized within band p16.1 of chromosome 4 by in situ hybridization. Am J Hum Genet (1986) 1.98
Prevalence of domestic violence in the United States. J Am Med Womens Assoc (1996) 1.82
Articular fractures: does an anatomic reduction really change the result? J Bone Joint Surg Am (2002) 1.74
Immunochemical properties of streptococcal M protein purified by isoelectric focusing. J Immunol (1975) 1.72
Expression of intestine-specific antigen reveals novel pathways of CD8 T cell tolerance induction. Immunity (2000) 1.67
Symptom clusters in cancer patients: a review of the literature. Curr Oncol (2007) 1.63
The importance of housing characteristics in determining Der p 1 levels in carpets in New Zealand homes. Clin Exp Allergy (2001) 1.61
Pharmacomechanical coupling in smooth muscle may involve phosphatidylinositol metabolism. Proc Natl Acad Sci U S A (1984) 1.58
Hemifacial myohyperplasia: description of a new syndrome. Am J Med Genet (2001) 1.58
The alternatively initiated c-Myc proteins differentially regulate transcription through a noncanonical DNA-binding site. Genes Dev (1994) 1.57
Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production. Mol Med (1998) 1.55
Health-related functional status in pregnancy: relationship to depression and social support in a multi-ethnic population. Obstet Gynecol (2001) 1.54
Tyrosine phosphorylation of pp125FAK in platelets requires coordinated signaling through integrin and agonist receptors. J Biol Chem (1994) 1.53
Systematic review: outcome of compensated cirrhosis due to chronic hepatitis C infection. Aliment Pharmacol Ther (2010) 1.51
Adhesive ligand binding to integrin alpha IIb beta 3 stimulates tyrosine phosphorylation of novel protein substrates before phosphorylation of pp125FAK. J Cell Biol (1993) 1.50
Exercise impacts brain-derived neurotrophic factor plasticity by engaging mechanisms of epigenetic regulation. Eur J Neurosci (2010) 1.48
Reducing falls and resulting hip fractures among older women. MMWR Recomm Rep (2000) 1.45
Microcell mediated chromosome transfer maps the Fanconi anaemia group D gene to chromosome 3p. Nat Genet (1995) 1.43
Intravenous infusion of a replication-selective adenovirus (ONYX-015) in cancer patients: safety, feasibility and biological activity. Gene Ther (2001) 1.42
Unilateral pupil dilation following head injury: thinking outside the (brain) box. QJM (2010) 1.37
Enzyme interactions in heparan sulfate biosynthesis: uronosyl 5-epimerase and 2-O-sulfotransferase interact in vivo. Proc Natl Acad Sci U S A (2001) 1.36
Neurotrophin-3 is required for proper cerebellar development. Nat Neurosci (1999) 1.34
Effect of concurrent acute infection with hepatitis C virus on acute hepatitis B virus infection. BMJ (1993) 1.34
Enterocyte expression of interleukin 7 induces development of gammadelta T cells and Peyer's patches. J Exp Med (2000) 1.34
A critical role for CD40-CD40 ligand interactions in amplification of the mucosal CD8 T cell response. J Exp Med (1999) 1.33
Differential requirements for ZAP-70 in TCR signaling and T cell development. J Immunol (1998) 1.31
Soluble antigen and CD40 triggering are sufficient to induce primary and memory cytotoxic T cells. J Immunol (2000) 1.29
Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formation. Cell Death Differ (1999) 1.26
Effects of cerebral ischemia in mice lacking DNA methyltransferase 1 in post-mitotic neurons. Neuroreport (2001) 1.21
Characterization of dual leucine zipper-bearing kinase, a mixed lineage kinase present in synaptic terminals whose phosphorylation state is regulated by membrane depolarization via calcineurin. J Biol Chem (1996) 1.21
Clinical differentiation between Proteus syndrome and hemihyperplasia: description of a distinct form of hemihyperplasia. Am J Med Genet (1998) 1.21
Genetic counseling of the deaf. Medical and cultural considerations. Ann N Y Acad Sci (1991) 1.20
Immortalization of four new Fanconi anemia fibroblast cell lines by an improved procedure. Somat Cell Mol Genet (1996) 1.20
Characterisation of melarsen-resistant Trypanosoma brucei brucei with respect to cross-resistance to other drugs and trypanothione metabolism. Mol Biochem Parasitol (1992) 1.19
Nutrition communication for a Latino community: formative research foundations. Fam Community Health (2001) 1.19
Use of geographic and genotyping tools to characterise tuberculosis transmission in Montreal. Int J Tuberc Lung Dis (2007) 1.18
Identification, molecular cloning, and characterization of dual leucine zipper bearing kinase. A novel serine/threonine protein kinase that defines a second subfamily of mixed lineage kinases. J Biol Chem (1994) 1.16
Methylprednisolone inhibition of TNF-alpha expression and NF-kB activation after spinal cord injury in rats. Brain Res Mol Brain Res (1998) 1.15
Independence of the chaperone activity of protein disulfide isomerase from its thioredoxin-like active site. J Biol Chem (1995) 1.14
The immunophenotyping of extramedullary myeloid cell tumors in paraffin-embedded tissue sections. Am J Surg Pathol (1988) 1.13
Interactions between stem cell factor and c-Kit are required for intestinal immune system homeostasis. Immunity (1994) 1.13
The Fanconi anemia complementation group C gene product: structural evidence of multifunctionality. Blood (2001) 1.13
Bacterial contamination of platelet concentrates stored at 20 degrees C. J Clin Pathol (1973) 1.11
Acetaldehyde increases procollagen type I and fibronectin gene transcription in cultured rat fat-storing cells through a protein synthesis-dependent mechanism. Hepatology (1991) 1.10
Stimulation of the mitogen-activated protein kinase cascade and tyrosine phosphorylation of the epidermal growth factor receptor by hepatopoietin. J Biol Chem (2000) 1.08
Unilateral microfibrillar abnormalities in a case of asymmetric Marfan syndrome. Am J Hum Genet (1990) 1.08
Bfl-1/A1 functions, similar to Mcl-1, as a selective tBid and Bak antagonist. Oncogene (2007) 1.05
Cytogenetics of 158 patients with regional or disseminated melanoma. Subset analysis of near-diploid and simple karyotypes. Cancer Genet Cytogenet (1995) 1.05
Cytologic evidence for gene amplification in methotrexate-resistant cells obtained from a patient with ovarian adenocarcinoma. J Clin Oncol (1984) 1.04
American Cancer Society guideline for the early detection of prostate cancer: update 1997. CA Cancer J Clin (1997) 1.04
Negative regulation of Pim-1 protein kinase levels by the B56beta subunit of PP2A. Oncogene (2007) 1.04
Role of calcium and calpain in complement-induced vesiculation of the platelet plasma membrane and in the exposure of the platelet factor Va receptor. Biochemistry (1990) 1.04
Mammalian SNM1 is required for genome stability. Mol Genet Metab (2008) 1.03
Genotypes of Cryptosporidium from Sydney water catchment areas. J Appl Microbiol (2005) 1.01
A light and electron microscopic study of ectopic tendon and ligament formation induced by bone morphogenetic protein-13 adenoviral gene therapy. J Neurosurg (2001) 1.01
Virus-associated deficiencies in the mitogen reactivity in celebes black macaques (Macaca nigra). Clin Immunol Immunopathol (1985) 1.01
Symptom clusters in cancer patients with brain metastases. Clin Oncol (R Coll Radiol) (2007) 1.01
American Cancer Society guidelines for the early detection of prostate cancer: update, June 10, 1997. Cancer (1997) 1.00
Regulation of glycoprotein IIb-IIIa receptor function studied with platelets permeabilized by the pore-forming complement proteins C5b-9. J Biol Chem (1992) 1.00
Further cytologic evidence for Xp-Yp translocation in XX males using in situ hybridization with Y-derived probe. Hum Genet (1987) 1.00
Apocrine ductal carcinoma in situ of the breast: histologic classification and expression of biologic markers. Hum Pathol (2001) 1.00
Tobacco in prisons: a focus group study. Tob Control (2009) 0.99
Newly described activating JAK3 mutations in T-cell acute lymphoblastic leukemia. Leukemia (2012) 0.99
Decreased functional connectivity between the amygdala and the left ventral prefrontal cortex in treatment-naive patients with major depressive disorder: a resting-state functional magnetic resonance imaging study. Psychol Med (2012) 0.98
Determinants of endotoxin levels in carpets in New Zealand homes. Indoor Air (2003) 0.98
A potential role for Dkk-1 in the pathogenesis of osteosarcoma predicts novel diagnostic and treatment strategies. Br J Cancer (2007) 0.98
The characterization and description of representatives of 'G' bacteria from activated sludge plants. Lett Appl Microbiol (1997) 0.97
BDNF supports mammalian chemoafferent neurons in vitro and following peripheral target removal in vivo. Dev Biol (1994) 0.96
Single dose doxycycline prophylaxis and peroperative bacteriological culture in elective colorectal surgery. Br J Surg (1981) 0.96
Dependence of developing group Ia afferents on neurotrophin-3. J Comp Neurol (1995) 0.95
PP2A-B56α controls oncogene-induced senescence in normal and tumor human melanocytic cells. Oncogene (2011) 0.95
Comparison between 201Tl and 99mTc sestamibi uptake during adenosine-induced vasodilation as a function of coronary stenosis severity. Circulation (1995) 0.95
Association between timing of zoledronic acid infusion and hip fracture healing. Osteoporos Int (2010) 0.94
Hypertrophic osteoarthropathy in a dog with a pulmonary abscess. J Am Vet Med Assoc (1967) 0.94
Goal post injuries in soccer. A laboratory and field testing analysis of a preventive intervention. Am J Sports Med (1995) 0.94
A novel pathway of thymus-directed T lymphocyte maturation. J Immunol (1994) 0.93
Lengths of immunolabeled ciliary microtubules in frog photoreceptor outer segments. Exp Eye Res (1987) 0.93
Ischemic brain damage in mice after selectively modifying BDNF or NT4 gene expression. J Cereb Blood Flow Metab (2000) 0.92
Giant bilateral myelolipomas in a man with congenital adrenal hyperplasia. J Clin Endocrinol Metab (2012) 0.92